Outcomes of medicaid patients undergoing TJA with previous positive urine toxicology screens

• Published in: European journal of orthopaedic surgery & traumatology Vol. 33; no. 8; pp. 3555 - 3560
• Main Authors: Moore, Michael, Shendrik, Irina, Roof, Mackenzie A., Sicat, Chelsea Sue, Meftah, Morteza, Schwarzkopf, Ran, Rozell, Joshua C.
• Format: Journal Article
• Language: English
• Published: Paris Springer Paris 01.12.2023; Springer Nature B.V
• Subjects: Medicaid; Medicine; Medicine & Public Health; Original Article; Prescription drugs; Surgical Orthopedics; Toxicology; Traumatic Surgery; Urine toxicology; Total knee arthroplasty; Total joint arthroplasty; Medicaid; Total hip arthroplasty; Opioids
• DOI: 10.1007/s00590-023-03591-1
• ISSN: 1432-1068; 1633-8065

Introduction Previous studies have demonstrated that patients with positive preoperative urine toxicology (utox) screens prior to total joint arthroplasty (TJA) have higher readmission rates, greater complication rates, and longer hospital stays compared to patients with negative screens. The aim of this study was to investigate the effect of postponing surgery for patients with positive preoperative utox in the Medicaid population. Methods This retrospective, observational study reviewed the Medicaid ambulatory database at a large, academic orthopedic specialty hospital for patients with a utox screen prior to TJA from 2012 to 2020. Patients were categorized into three groups: (1) controls with negative preoperative utox or a utox consistent with prescription medications (Utox−) with TJA completed as scheduled; (2) positive preoperative utox with TJA rescheduled and surgery completed on a later date (R-utox+); (3) positive preoperative utox inconsistent with prescription medications with TJA completed as scheduled (S-utox+). Primary outcomes included mortality, 90-day readmission rate, complication rate, and length of stay. Results Of the 300 records reviewed, 185 did not meet inclusion criteria. The remaining 115 patients included 80 (69.6%) Utox−, 5 (6.3%) R-utox+, and 30 (37.5%) S-utox+. Mean follow-up time was 49.6 months. Hospital stays trended longer in the Utox− group (3.7 ± 2.0 days vs. 3.1 ± 1.6 S-utox+ vs.2.5 ± 0.4 R-utox+, p  = 0.20). Compared to the R-utox+group, the S-utox+ group trended toward lower home discharge rates ( p  = 0.20), higher in-hospital complication rates ( p  = 0.85), and more all-cause 90-day emergency department visits ( p  = 0.57). There were no differences in postoperative opioid utilization between groups ( p  = 0.319). Duration of postoperative narcotic use trended toward being longer in the Utox− patients (820.7 ± 1073.8 days vs. 684.6 ± 1491.8 S-utox+ vs. 585.1 ± 948.3 R-utox+, p  = 0.585). Surgical time ( p  = 0.045) and revision rates ( p  = 0.72) trended toward being higher in the S-utox+ group. Conclusions Medicaid patients with positive preoperative utox who had surgeries postponed trended towards shorter hospital stays and greater home discharge rates. Larger studies should be conducted to analyze the implications of a positive preoperative utox on risk profiles and outcomes following TJA in the Medicaid population. Study design Retrospective cohort study.